Wound botulism in heroin addicts in Germany;Wundbotulismus bei heroinabhängigen in Deutschland

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 18, 2006, Pages 1023-1028

  Kuhn, Jens ^a   Gerbershagen, K ^b   Schaumann, R ^c   Langenberg, U ^b   Rodloff, A C ^c   Mueller, W ^b   Hartmann Klosterkoetter, U ^b   Bewermeyer, H ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Drug addicts; Germany; Heroin; Wound botulismus

Indexed keywords

ANTIBIOTIC AGENT; ANTITOXIN; ANTIINFECTIVE AGENT; BOTULINUM ANTISERUM; DIAMORPHINE;

ADULT; ANAMNESIS; ARTICLE; BOTULISM; CASE REPORT; FEMALE; HEROIN DEPENDENCE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MALE; PHYSICAL EXAMINATION; SYMPTOMATOLOGY; CLOSTRIDIUM BOTULINUM; COMPARATIVE STUDY; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GERMANY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TIME; TREATMENT OUTCOME; WOUND INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BOTULINUM ANTITOXIN; BOTULISM; CLOSTRIDIUM BOTULINUM; DEBRIDEMENT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEROIN; HEROIN DEPENDENCE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; WOUND INFECTION;

EID: 33744992715     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939889     Document Type: Article

References (17)

1. Akbulut D, Dennis J, Gent M et al. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill 2005; 10: in press
2. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism. Euro Surveill 2004; 9: E13-14
3. Brett MM, Hallas C, Mpamugo O. Wound botulism in the UK and Ireland. J Med Microbiol 2004; 53: 555-561
4. Critchley EM, Hayes PJ, Isaacs PE. Outbreak of botulism in north west England and Wales, June. 1989. Lancet 1989; 2: 849-853
5. Herr K, Schwarz U, Dazzi H. Antitoxinbehandlung bei Wundbotulismus nach Drogeninjektion. Schweiz Med Forum 2002; 22: 540-542
6. Hiersemenzel LP, Jermann M, Waespe W. Deszendierende Lähmung durch Wundbotulismus. Eine Falldarstellung. Nervenarzt 2000; 71: 130-133
7. Lindström M, Keto R et al. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Appl Environ Microbiol 2001; 67: 5694-5699
8. MacDonald KL, Rutherford GW, Friedman SM et al. Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med 1985; 102: 616-618
9. Merrison AFA, Chidley KE, Dunnett J, Sieradzan KA. Lesson of the week: Wound botulism associated with subcutaneous drug use. BMJ 2002; 325: 1020-1021
10. Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA 1998; 279: 859-853
11. Robert Koch-Institut. Epidemiologisches Bulletin 43/2004. 2004
12. Sandrock CE, Murin S. Clinical Predictors of Respiratory Failure and Longterm Outcome in Black Tar Heroin-Associated Wound Botulism. Chest 2001; 120: 562-566
13. Scheibe F, Hug B, Rossi M. Wound botulism after drug injection. Dtsch Med Wochenschr 2002; 127: 199-202
14. Schweizer-Bundesamt-für-Gesundheit. Ein Fall von Wundbotulismus. Bull BAG, Bern, 1999: 68-69
15. Shapiro RL HC, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 1998; 129: 221-228
16. Takeshi K, Fujinaga Y, Inoue K et al. Simple method for detection of Clostridium botulinum type A to F neurotoxin genes by ploymerase chain reaction. Microbiol Immunol 1996; 40: 5-11
17. Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951-1998. Clin Infect Dis 2000; 31: 1018-1024